arrow_back Back to App

Protecting 340B Drug Discount Program: Ensuring Fair Treatment for Pharmacies

This act aims to protect the 340B drug discount program, which helps hospitals and clinics provide more affordable medications to low-income patients. It prevents discrimination against healthcare providers and pharmacies participating in this program by insurers and pharmacy benefit managers. This ensures patients continue to access discounted drugs and healthcare facilities can better support those in need.
Key points
Prohibition of Discrimination: Insurers and pharmacy benefit managers cannot treat healthcare facilities and pharmacies offering 340B discounted drugs unfairly.
Equal Reimbursement Rules: 340B facilities and pharmacies must receive the same payments for drugs as other pharmacies, regardless of offering discounts.
Penalties for Violations: Companies violating the new rules may face fines of up to $5,000 per day.
Patient Protection: The act aims to ensure patients retain their choice of pharmacy and access to more affordable medications.
Preventing Duplicate Discounts: Mechanisms are introduced to avoid situations where facilities receive double discounts on the same drugs in the Medicaid program.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2534
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7]
Process start date: 2023-04-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PROTECT 340B Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2534.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-04-06.

What are the main provisions?

Key points include:

  • Prohibition of Discrimination: Insurers and pharmacy benefit managers cannot treat healthcare facilities and pharmacies offering 340B discounted drugs unfairly.
  • Equal Reimbursement Rules: 340B facilities and pharmacies must receive the same payments for drugs as other pharmacies, regardless of offering discounts.
  • Penalties for Violations: Companies violating the new rules may face fines of up to $5,000 per day.
  • Patient Protection: The act aims to ensure patients retain their choice of pharmacy and access to more affordable medications.
  • Preventing Duplicate Discounts: Mechanisms are introduced to avoid situations where facilities receive double discounts on the same drugs in the Medicaid program.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Spanberger, Abigail Davis [D-VA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health